High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
Recruiting · NCT06972602 · Registry updated 2025-05-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed | Disease Attributes, Eye Diseases, Hereditary, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, epithelial neoplasm, eye disorder, neoplasm, neuroepithelial neoplasm, ocular cancer, primitive neuroectodermal tumor, retinal cancer, retinal disorder, retinoblastoma | Recruiting | Early phase 1 | 2025-05-15 | NCT06972602 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eye & ENT Hospital of Fudan University | 64 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan Eye & ENT Hospital | Shanghai | China | 1 |